dis 1

25 questions • 2024-08-28
Jef Marc Valencia
Report

Question

the process that destroys complement activity,

Answer

Question

known to interfere with the reactions of certain syphilis tests and complement components (e.g., C1may also cause lysis of the indicator cells in hemagglutination assays.

Answer

Question

cause a false-positive reaction in latex passive agglutination assays.

Answer

Question

contains high levels of bilirubin.

Answer

Question

Normal Bilirubin level

Answer

Question

This exceeds 1.5 mg/dl bilirubin

Answer

Question

interfere with antigen- antibody reaction by blocking binding sites on antibodies

Answer

Question

Serum samples containing more than 100 mg/dL of hemoglobin can cause

Answer

Question

done to allow separation of the cells and clotting factors and to avoid the formation of fibrin clots while still maintaining proteins and other molecules that represent the body's circulation when centrifuged

Answer

Question

preferred sample to use in serologic testing

Answer

dis 1

TestMaker

Score

0 / 10

Correct rate

0%

Correct: 0

Incorrect: 0

Unanswered: 10

 
ankimaker.com

Question list

  • 1

    the process that destroys complement activity,

    SERUM INACTIVATION

  • 2

    known to interfere with the reactions of certain syphilis tests and complement components (e.g., C1may also cause lysis of the indicator cells in hemagglutination assays.

    COMPLEMENT

  • 3

    cause a false-positive reaction in latex passive agglutination assays.

    AGGLUTINATE LATEX PARTICLE

  • 4

    contains high levels of bilirubin.

    ICTERIC SAMPLE

  • 5

    Normal Bilirubin level

    0.5 mg/dl

  • 6

    This exceeds 1.5 mg/dl bilirubin

    HYPERBILIRUBINEMIA

  • 7

    interfere with antigen- antibody reaction by blocking binding sites on antibodies

    LIPOPROTEIN

  • 8

    Serum samples containing more than 100 mg/dL of hemoglobin can cause

    NON-SPECIFIC BINDING

  • 9

    done to allow separation of the cells and clotting factors and to avoid the formation of fibrin clots while still maintaining proteins and other molecules that represent the body's circulation when centrifuged

    COMPLETE CLOTTING

  • 10

    preferred sample to use in serologic testing

    SERUM

  • 11

    Reasons why serum is used in serologic testing

    ANTIBODIES, NO ANTICOAGULANT, NO FIBRINOGEN

  • 12

    Based on the capacity of the tube, how much NSS is added and how many times it is repeated

    3/4, 3

  • 13

    common reagent used for many serologic procedures provide the appropriate serum to cell ratio to allow for grading and interpretation of test results.

    RED CELL SUSPENSION

  • 14

    contains the fibrinogen group of coagulation factors • lighter yellow and little turbid • chemically, does not contain much platelet derivatives

    PLASMA

  • 15

    Liquid portion of unclotted blood

    PLASMA

  • 16

    liquid portion of clotted blood

    SERUM

  • 17

    does not contain the fibrinogen group of coagulation factors • darker yellow and clearer • contains higher levels of platelet deriva tives

    SERUM

  • 18

    Last resort for blood collection

    SUPERFICIAL VEIN OF THE FOOT

  • 19

    needed to prepare the required RCS concentration.

    PRBC

  • 20

    Older than 3 yrs old site of collection

    VEIN ON THE ANTECUBITAL FOSSA

  • 21

    Prolonged toruniquet application can cause

    HEMOCONCENTRATION

  • 22

    Recommends wearing gloves when collecting or handling blood and body fluids contaminated with blood and wearing face shields when there is danger of blood splashing on mucous membranes and when disposing of all needles and sharp objects in puncture-resistant containers

    UNIVERSAL PRECAUTION 1987

  • 23

    guidelines are not limited to blood-borne pathogens; they consider all body fluids and moist body substances to be potentially infectious.

    BODY SUBSTANCE ISOLATION

  • 24

    the CDC combined the major features of UP and BSI guidelines.

    STANDARD PRECAUTIONS 1996

  • 25

    NCCLS meaning

    NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARD